Roche Holding AG has finalised its acquisition of LumiraDx’s innovative Point of Care technology, a strategic move aimed at enhancing its diagnostic portfolio and expanding global access to essential healthcare. The completion of this acquisition, following all necessary antitrust and regulatory approvals, marks a significant milestone for Roche as it integrates LumiraDx’s multi-assay point of […]
US-based Vedanta Biosciences has raised $27 million in a Series C financing round to accelerate its pioneering work on microbiome-derived therapeutics. The funding round attracted prominent backers, including the Bill & Melinda Gates Foundation, Bristol-Myers Squibb, Rock Springs Capital, Invesco Asset Management, Seventure Partners, and its founder, PureTech Health. Pipeline advancement plans The company plans […]
